TokeOni Analog - seMpai: Properties and Applications


Bioluminescence imaging (BLI) has been an indispensable technique for noninvasive and highly sensitive observation of biological events in living tissues1-3. Firefly luciferase (Fluc) and D-luciferin have been a standard bioluminescence system for noninvasive small animal imaging. This bioluminescence system generates light signals within visible wavelength (λmax = 560 nm) where light is highly absorbed by hemoglobin and melanin4,5. This fact motivated us to develop a bioluminescence system generating near-infrared light that could penetrate living tissues deeply. Maki et al. evaluated synthetic substrate TokeOni (aka AkaLumine-HCl) (Product No. 808350) that emits near-infrared (λmax = 677 nm) in the reaction with native Fluc6. BLI imaging with TokeOni successfully achieved highly sensitive imaging of deep tissues7. However, poor solubility (< 1 mM) of TokeOni in neutral-buffered aqueous media limits its applications in some biological experiments.

Highly soluble TokeOni analog: seMpai for highly sensitivity deep tissue imaging in neutral buffer conditions

We are now introducing a newly synthesized substrate, seMpai (Product No: 902268), a TokeOni analog that emits near-infrared bioluminescence in the reaction with Fluc, similar to TokeOni (Figure 1). In addition, seMpai offers high solubility (> 60 mM) in neutral-buffered aqueous media and is stable for several months under -80 ˚C.


Figure 1.Chemical structures and bioluminescent spectrums of SeMpai, D-luciferin and TokeOni.

Detection of lung metastasis in mice demonstrated that the detection sensitivity of seMpai is higher than that of D-luciferin (Figure 2) and is comparable with that of TokeOni8.


Figure 2.Highly-sensitive noninvasive imaging of lung metastasis with seMpai. The murine lung metastasis was established 2 weeks after intravenous injection of LLC/Fluc cells into B6 albino mice. The bioluminescence images were acquired 15 minutes after intraperitoneal administration of D-luciferin or seMpai (120 μMol / kg).


Overall results suggest that seMpai is a suitable substrate of near-infrared BLI for many biological experiments. Its high solubility in neutral buffer conditions further extends the bioluminescent application of TokeOni derivatives.



Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, Ross BD. 2000. Rapid and Quantitative Assessment of Cancer Treatment Response Using In Vivo Bioluminescence Imaging. Neoplasia. 2(6):491-495.
Luker KE, Smith MCP, Luker GD, Gammon ST, Piwnica-Worms H, Piwnica-Worms D. 2004. Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proceedings of the National Academy of Sciences. 101(33):12288-12293.
Kuchimaru T, Kataoka N, Nakagawa K, Isozaki T, Miyabara H, Minegishi M, Kadonosono T, Kizaka-Kondoh S. 2018. A reliable murine model of bone metastasis by injecting cancer cells through caudal arteries. Nat Commun. 9(1):
Dawson JB, Barker DJ, Ellis DJ, Cotterill JA, Grassam E, Fisher GW, Feather JW. 1980. A theoretical and experimental study of light absorption and scattering by in vivo skin. Phys. Med. Biol.. 25(4):695-709.
Weissleder R, Ntziachristos V. 2003. Shedding light onto live molecular targets. Nat Med. 9(1):123-128.
Iwano S, Obata R, Miura C, Kiyama M, Hama K, Nakamura M, Amano Y, Kojima S, Hirano T, Maki S, et al. 2013. Development of simple firefly luciferin analogs emitting blue, green, red, and near-infrared biological window light. Tetrahedron. 69(19):3847-3856.
Kuchimaru T, Iwano S, Kiyama M, Mitsumata S, Kadonosono T, Niwa H, Maki S, Kizaka-Kondoh S. 2016. A luciferin analogue generating near-infrared bioluminescence achieves highly sensitive deep-tissue imaging. Nat Commun. 7(1):
Yeh H, Xiong Y, Wu T, Chen M, Ji A, Li X, Ai H. 2019. ATP-Independent Bioluminescent Reporter Variants To Improve in Vivo Imaging. ACS Chem. Biol.. 14(5):959-965.

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.